TechInvention ties up with Korean co to bring oral cholera vaccine to India

Clinical trials of WHO pre-qualified vaccine to start soon; Unicef price is $2 per dose, private market price globally is $8-10; Initial volumes to be imported; India would need 83 mn doses a year

Biotech company TechInvention has tied up with South Korean firm Eubiologics to bring in an oral cholera vaccine to India. The vaccine doses would be imported initially.

Euvichol, the vaccine, has about 80 per cent efficacy in adults and about 89 per cent in children, TechInvention claimed. It is prequalified by the World Health Organisation (WHO). Eubiologics has so far supplied 55 million doses to UN healthcare agencies. Euvichol-Plus has been supplied to 22 countries across the globe, it added.  

TechInvention Founder and CEO Syed Ahmed said, “Earlier Shantha Biotech was manufacturing the Cholera vaccine. The company got acquired by